Definitive Contract 75D30120C09259
Award Date
8/21/20
Potential Completion Date
12/16/23
Potential Value
$11M
Federal Agency
CDC Pittsburgh
Awardee
Marshfield Clinic, Inc.
Ultimate Awardee
Marshfield Clinic Health System, Inc.
NAICS Category
622110 - General Medical and Surgical Hospitals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Marshfield, WI, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Marshfield Clinic has been awarded a definitive cost-no-fee contract valued at $22.6 million by the Centers for Disease Control and Prevention to provide centralized molecular assessment of SARS and influenza virus infections for multi-site prospective cohorts. The contract will support the CDC's efforts to respond to the Coronavirus COVID-19 pandemic through prospective cohort studies and molecular testing of samples from infected individuals. Marshfield Clinic will serve as the prime...
Marshfield Clinic, Inc. was awarded a $1,725,838 firm fixed price definitive contract from the Centers for Disease Control and Prevention (CDC) to support Topic 9 under the Fiscal Year 2021 Broad Agency Announcement. As the prime contractor, Marshfield Clinic will provide services related to the specified topic in Marshfield, Wisconsin through September 30, 2022. No set-aside designation was applied to this contract. Marshfield Clinic is a non-profit health care organization that conducts...
This is a $1,439,648.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization, for a serum repository project. The contract has an ultimate completion date of September 24, 2028 and was awarded on September 22, 2023. Marshfield Clinic, Inc. is a subsidiary of the Marshfield Clinic Health System, Inc., which has performed significant contract work with the CDC, including COVID-19...
Marshfield Clinic, Inc. was awarded a $200,030 firm fixed price purchase order by the Centers for Disease Control and Prevention to conduct a follow-up measles, mumps, and rubella vaccine response study. The award was made without a set-aside designation under a June 2020 solicitation seeking a contractor to perform targeted DNA sequencing of samples from participants in the Centers for Disease Control and Prevention's MMR3 Long-Term Follow-Up Study. Marshfield Clinic will sequence genomic...
This $19,981,955 firm fixed price contract was awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic Health System, Inc., a non-profit healthcare organization, to provide centralized molecular testing and analysis services to support the CDC's monitoring efforts for SARS-CoV-2 and influenza viruses. The contract includes assessing the effectiveness of COVID-19 vaccines. This award is not associated with a set-aside program. In addition to serving as a prime...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,290,867.00 firm fixed-price contract to the University of Wisconsin System to conduct research on defining the role of college students in the spread of SARS-CoV-2 in the Upper Midwest. This contract was awarded under the CDC's Broad Agency Announcement Number 75D301-20-R-68024, which solicited white papers for research projects addressing COVID-19 transmission, protection, prevention, and control...
Marshfield Clinic, Inc. has been awarded a definitive cost-no-fee contract from the Department of Health and Human Services Centers for Disease Control and Prevention valued at up to $424,312. The contract calls for an epidemiologic assessment of Lyme disease diagnoses in electronic health records to support the agency's objectives. As the prime contractor, Marshfield Clinic will analyze Lyme disease data extracted from electronic health records to provide epidemiologic insights. The contract...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization, to enhance the serum repository for Lyme disease. The contract has a ceiling value of $237,421.00 and a completion date of September 24, 2022. Marshfield Clinic has a long history of partnering with the CDC and other federal agencies on public health initiatives, including vaccine safety monitoring and COVID-19 research. This...
This $1,989,636.00 cost-plus-fixed-fee contract was awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization, to conduct a study on the measles, mumps, and rubella vaccine (MMR3 STUDY). The contract has an ultimate completion date of May 9, 2012. Marshfield Clinic, Inc. is a long-standing partner with the CDC, having supported various public health initiatives and vaccine safety monitoring efforts through federal contracts...
The Centers for Disease Control and Prevention (CDC) awarded a $658,016 definitive contract to Marshfield Clinic, Inc. for "OPTIMAL STRATEGIES TO ESTIMATE THE RELATIVE EFFECTIVENESS OF INFLUENZA VACCINES". This contract, which has a term ending on March 17, 2025, is not set aside. Marshfield Clinic, Inc., a non-profit healthcare organization, will be providing services related to evaluating the effectiveness of influenza vaccines. This contract is part of a larger Vaccine Safety...